Vir Biotechnology, Inc. (VIR)
6.55
-0.11
(-1.65%)
USD |
NASDAQ |
Dec 10, 16:00
6.68
+0.13
(+1.98%)
Pre-Market: 08:57
Vir Biotechnology Profit Margin (Quarterly): -67.98K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Vistagen Therapeutics, Inc. | -7.53K% |
| Bristol Myers Squibb Co. | 17.96% |
| NovaBay Pharmaceuticals, Inc. | -255.9% |
| Palatin Technologies, Inc. | 52.87% |
| Theriva Biologics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -48.24% |
| Return on Assets | -38.78% |
| Return on Invested Capital | -43.92% |
| Gross Profit Margin (Quarterly) | -1.14K% |
| Operating Margin (Quarterly) | -72.03K% |
| Return on Net Operating Assets | -332.2% |